Clinical trial
Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With…
NCT00006199 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00006199 |
|---|---|
| Title | Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32) |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | R115777 (farnesyl transferase inhibitor), Topotecan |
| First posted | Sep 11, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: